Fleas and smaller fleas: Virotherapy for parasite infections

Trends in Microbiology

Volumn 21, Issue 5, 2013, Pages 215-220

  Hyman, Paul ^a   Atterbury, Robert ^b   Barrow, Paul ^b  

^a ASHLAND UNIVERSITY   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Bacteriophage; Parasite; Phage therapy; Protists; Protozoan; Virotherapy; Virus

Indexed keywords

BACTERIAL DNA; BACTERIOPHAGE DNA; COLICIN; DOUBLE STRANDED DNA; DOUBLE STRANDED RNA; VIRULENCE FACTOR;

BABESIA; BACTERIOPHAGE; BIOLOGICAL PEST CONTROL; CHOLERA; EIMERIA; ENTEROBIUS; ENTEROTOXIGENIC ESCHERICHIA COLI; GENETIC VARIABILITY; GIARDIA; HOST PATHOGEN INTERACTION; HUMAN; INFECTION CONTROL; LEISHMANIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITOSIS; PRIORITY JOURNAL; REVIEW; TRICHOMONAS; VIRION; VIROTHERAPY; VIRUS GENOME; VIRUS LIKE AGENT;

ANIMALS; BIOLOGICAL THERAPY; HUMANS; PARASITES; PARASITIC DISEASES; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUSES;

ANIMALIA; BACTERIA (MICROORGANISMS); PROTISTA; PROTOZOA; SIPHONAPTERA (FLEAS);

EID: 84877101465     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.02.006     Document Type: Review

References (39)

1. Guenther S., Loessner M. Bacteriophage biocontrol of Listeria monocytogenes on soft ripened white mold and red-smear cheeses. Bacteriophage 2011, 1:94-100.
2. Tan C.M., et al. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci. Transl. Med. 2012, 21:126ra35.
3. Muthana M., et al. Macrophage delivery of an oncolytic virus abolishes tumor regrowth and metastasis after chemotherapy or irradiation. Cancer Res. 2012, 73:490-495.
4. Garber K. China approves world's first oncolytic virus therapy for cancer treatment. J. Natl. Cancer Inst. 2006, 98:298-300.
5. Diamond L.S., et al. Viruses of Entamoeba histolytica. I. Identification of transmissible virus-like agents. J. Virol. 1972, 9:326-341.
6. Garnham P.C., et al. Electron microscope studies of motile stages of malaria parasites. III. The ookinetes of Haemamoeba and Plasmodium. Trans. R. Soc. Trop. Med. Hyg. 1962, 56:116-125.
7. Lemgruber L., Lupetti P. Crystalloid body, refractile body and virus-like particles in Apicomplexa: what is in there?. Parasitology 2012, 139:285-293.
8. Wileman T. Aggresomes and pericentriolar sites of virus assembly: cellular defense or viral design?. Annu. Rev. Microbiol. 2007, 61:149-167.
9. Claverie J.M., Abergel C. Mimivirus: the emerging paradox of quasi-autonomous viruses. Trends Genet. 2010, 26:431-437.
10. Iyer L.M., et al. Common origin of four diverse families of large eukaryotic DNA viruses. J. Virol. 2001, 75:11720-11734.
11. Hyman P., Abedon S. Smaller fleas: viruses of microorganisms. Scientifica 2012, 2012:734023.
12. Wang A.L., Wang C.C. Viruses of protozoa. Annu. Rev. Microbiol. 1991, 45:251-263.
13. Benchimol M., et al. Virus in Trichomonas - an ultrastructural study. Parasitol. Int. 2002, 51:293-298.
14. Mattern C.F., et al. Viruses of Entamoeba histolytica. I. Identification of transmissible virus-like agents. J. Virol. 1972, 9:342-358.
15. Schuster F.L., Dunnebacke T.H. Virus-like particles and an unassociated infectious agent in amoebae of the genus Naegleria. Ann. Soc. Belg. Med. Trop. 1974, 54:359-370.
16. Wang A.L., et al. Giardiavirus double-stranded RNA genome encodes a capsid polypeptide and a gag-pol-like fusion protein by a translation frameshift. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8595-8599.
17. Alderete J.F., et al. Phenotypes and protein-epitope phenotypic variation among fresh isolates of Trichomonas vaginalis. Infect. Immun. 1987, 55:1037-1041.
18. Miller R.L., et al. Purification and characterization of the Giardia lamblia double-stranded RNA virus. Mol. Biochem. Parasitol. 1988, 28:189-196.
19. Marche S., et al. RNA virus-like particles in pathogenic plant trypanosomatids. Mol. Biochem. Parasitol. 1993, 57:261-268.
20. Ives A., et al. Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 2011, 331:775-778.
21. del Cacho E., et al. Eimeria necatrix virus: intracellular localisation of viral particles and proteins. Int. J. Parasitol. 2001, 31:1269-1274.
22. Revets H., et al. Identification of virus-like particles in Eimeria stiedae. Mol. Biochem. Parasitol. 1989, 36:209-216.
23. Roditi I., et al. Virus-like particles in Eimeria nieschulzi are associated with multiple RNA segments. Mol. Biochem. Parasitol. 1994, 63:275-282.
24. Fraga J., et al. Genetic characterization of three Cuban Trichomonas vaginalis virus. Phylogeny of Totiviridae family. Infect. Genet. Evol. 2012, 12:113-120.
25. Brüssow H., Kutter E. Phage ecology. Bacteriophages: Biology and Applications 2005, 129-164. CRC Press. E. Kutter, A. Sulakvelidze (Eds.).
26. Ackermann H.W. Frequency of morphological phage descriptions in the year 2000. Brief Rev. Arch. Virol. 2001, 146:843-857.
27. Ackermann H.W. Bacteriophage observations and evolution. Res. Microbiol. 2003, 154:245-251.
28. Suttle C.A. The significance of viruses to mortality in aquatic microbial communities. Microb. Ecol. 1994, 28:237-243.
29. Labrie S.J., et al. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 2010, 8:317-327.
30. Clokie M.R., et al. Phages in nature. Bacteriophage 2011, 1:31-45.
31. Wagner P.L., Waldor M.K. Bacteriophage control of bacterial virulence. Infect. Immun. 2002, 70:3985-3993.
32. Brussow H., et al. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol. Mol. Biol. Rev. 2004, 68:560-602.
33. Chanishvili N. Phage therapy - history from Twort and d'Herelle through Soviet experience to current approaches. Adv. Virus Res. 2012, 83:3-40.
34. Loc-Carrillo C., et al. Phage therapy of wounds and related purulent infections. Bacteriophages in Health and Disease 2012, 185-202. CAB International. P. Hyman, S.T. Abedon (Eds.).
35. Smith H.W., Huggins M.B. Treatment of experimental Escherichia coli infection in mice with colicine V. J. Med. Microbiol. 1977, 10:479-482.
36. Smith H.W., Huggins M.B. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol. 1982, 128:307-318.
37. Barrow P.A., et al. Use of lytic bacteriophage for control of experimental Escherichia coli septicaemia and meningitis in chickens and calves. Clin. Diagn. Lab. Immunol. 1998, 5:294-298.
38. Smith H.W., Huggins M.B. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 1983, 128:307-318.
39. Soothill J.S. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 1994, 20:209-211.